US' Elevance to start commercial ops at Indonesia plant by end-'13

27 June 2013 04:55  [Source: ICIS news]

SINGAPORE (ICIS)--US-based Elevance Renewable Sciences plans to begin commercial production at its new joint venture biorefinery at Gersik, Indonesia, by the end of 2013, a company executive said on Thursday.

"The plant is going through commissioning and will begin commercial operations later this year," said Gregory Gerhardt, market development manager at Elevance.

The 180,000 tonnes/year biorefinery - a joint venture with Singapore-listed agribusiness firm Wilmar International - will produce high-value performance chemicals, advanced biofuels and oleochemicals, according to the company's website.

The facility will be capable of operating using multiple renewable oil feedstocks, such as palm, mustard, soybean, jatropha or waste oils, it said.

Gerhardt was speaking at the sidelines of the 7th ICIS Asian Base Oils and Lubricants Conference in Singapore. The two-day event ends on 27 June.

The biorefinery's capacity could be expanded to up to 360,000 tonnes/year, according to Gerhardt. He declined to reveal the company's expansion plans for the facility.

Meanwhile, the company is currently "retrofitting" an existing refinery located at Natchez in Mississippi, the US, to convert it into a world-scale biorefinery, Gerhardt said.

The exact timeline for the start-up of this new facility in the US has not yet been finalised, he added.


By: Nurluqman Suratman



AddThis Social Bookmark Button

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly

ICIS news FREE TRIAL
Get access to breaking chemical news as it happens.
ICIS Global Petrochemical Index (IPEX)
ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index